- Home
- BTAI vs WAVE Comparison
BTAI vs WAVE Comparison
Compare BTAI & WAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- WAVE
- Stock Information
- Founded
- BTAI 2017
- WAVE 2011
- Country
- BTAI United States
- WAVE Israel
- Employees
- BTAI N/A
- WAVE N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- WAVE Electric Utilities: Central
- Sector
- BTAI Health Care
- WAVE Utilities
- Exchange
- BTAI Nasdaq
- WAVE Nasdaq
- Market Cap
- BTAI 48.3M
- WAVE 46.0M
- IPO Year
- BTAI 2018
- WAVE 2021
- Fundamental
- Price
- BTAI $2.05
- WAVE $7.60
- Analyst Decision
- BTAI Buy
- WAVE Strong Buy
- Analyst Count
- BTAI 5
- WAVE 1
- Target Price
- BTAI $32.80
- WAVE $15.00
- AVG Volume (30 Days)
- BTAI 987.3K
- WAVE 38.5K
- Earning Date
- BTAI 11-12-2025
- WAVE 11-20-2025
- Dividend Yield
- BTAI N/A
- WAVE N/A
- EPS Growth
- BTAI N/A
- WAVE N/A
- EPS
- BTAI N/A
- WAVE N/A
- Revenue
- BTAI $868,000.00
- WAVE $168,000.00
- Revenue This Year
- BTAI N/A
- WAVE $203.57
- Revenue Next Year
- BTAI $614.78
- WAVE $160.00
- P/E Ratio
- BTAI N/A
- WAVE N/A
- Revenue Growth
- BTAI N/A
- WAVE N/A
- 52 Week Low
- BTAI $1.17
- WAVE $4.41
- 52 Week High
- BTAI $12.16
- WAVE $17.63
- Technical
- Relative Strength Index (RSI)
- BTAI 34.65
- WAVE 42.85
- Support Level
- BTAI $2.14
- WAVE $7.50
- Resistance Level
- BTAI $2.46
- WAVE $8.12
- Average True Range (ATR)
- BTAI 0.16
- WAVE 0.45
- MACD
- BTAI -0.00
- WAVE -0.05
- Stochastic Oscillator
- BTAI 9.03
- WAVE 9.09
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.